# Maxlinear, Inc: financial statements, quarterly

MXL · Nasdaq · CIK 1288469 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mxl.md) · [Financials](/companies/mxl/financials.md) · [Filings](/companies/mxl/filings.md) · [Insiders](/companies/mxl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mxl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [125 d](/filings/0001288469-26-000011.md) | [95.3](/filings/0001288469-25-000029.md) | [92.0](/filings/0001288469-25-000079.md) | [81.1](/filings/0001288469-25-000097.md) | [92.2 d](/filings/0001288469-26-000011.md) | [95.9](/filings/0001288469-26-000029.md) | [109](/filings/0001288469-26-000051.md) | [126](/filings/0001288469-26-000061.md) | [136 d](/filings/0001288469-26-000011.md) | [137](/filings/0001288469-26-000029.md) | [169](/filings/0001288469-26-000051.md) | [218](/filings/0001288469-26-000061.md) |
| Cost of revenue | $m | [56.8 d](/filings/0001288469-26-000011.md) | [46.0](/filings/0001288469-25-000029.md) | [41.8](/filings/0001288469-25-000079.md) | [37.0](/filings/0001288469-25-000097.md) | [40.9 d](/filings/0001288469-26-000011.md) | [42.1](/filings/0001288469-26-000029.md) | [47.3](/filings/0001288469-26-000051.md) | [54.6](/filings/0001288469-26-000061.md) | [57.9 d](/filings/0001288469-26-000011.md) | [58.3](/filings/0001288469-26-000029.md) | [71.2](/filings/0001288469-26-000051.md) | [90.0](/filings/0001288469-26-000061.md) |
| Gross profit | $m | [68.5 d](/filings/0001288469-26-000011.md) | [49.3](/filings/0001288469-25-000029.md) | [50.2](/filings/0001288469-25-000079.md) | [44.1](/filings/0001288469-25-000097.md) | [51.2 d](/filings/0001288469-26-000011.md) | [53.8](/filings/0001288469-26-000029.md) | [61.5](/filings/0001288469-26-000051.md) | [71.9](/filings/0001288469-26-000061.md) | [78.6 d](/filings/0001288469-26-000011.md) | [78.9](/filings/0001288469-26-000029.md) | [97.7](/filings/0001288469-26-000051.md) | [128](/filings/0001288469-26-000061.md) |
| Selling, general and administrative | $m | [34.4 d](/filings/0001288469-26-000011.md) | [36.5](/filings/0001288469-25-000029.md) | [33.6](/filings/0001288469-25-000079.md) | [30.2](/filings/0001288469-25-000097.md) | [38.1 d](/filings/0001288469-26-000011.md) | [36.6](/filings/0001288469-26-000029.md) | [33.4](/filings/0001288469-26-000051.md) | [47.7](/filings/0001288469-26-000061.md) | [42.0 d](/filings/0001288469-26-000011.md) | [42.5](/filings/0001288469-26-000029.md) | [45.8](/filings/0001288469-26-000051.md) | [36.9](/filings/0001288469-26-000061.md) |
| Operating income | $m | [(41.7) d](/filings/0001288469-26-000011.md) | [(74.6)](/filings/0001288469-25-000029.md) | [(40.8)](/filings/0001288469-25-000079.md) | [(66.7)](/filings/0001288469-25-000097.md) | [(41.2) d](/filings/0001288469-26-000011.md) | [(46.1)](/filings/0001288469-26-000029.md) | [(24.6)](/filings/0001288469-26-000051.md) | [(41.3)](/filings/0001288469-26-000061.md) | [(14.9) d](/filings/0001288469-26-000011.md) | [(17.2)](/filings/0001288469-26-000029.md) | [(4.2)](/filings/0001288469-26-000051.md) | [30.2](/filings/0001288469-26-000061.md) |
| Interest expense | $m | [2.9 d](/filings/0001288469-24-000015.md) | [2.7](/filings/0001288469-24-000064.md) | [2.7](/filings/0001288469-25-000079.md) | [2.7](/filings/0001288469-25-000097.md) | [2.8 d](/filings/0001288469-26-000011.md) | [2.5](/filings/0001288469-26-000029.md) | [2.5](/filings/0001288469-26-000051.md) | [2.6](/filings/0001288469-26-000061.md) | [2.4 d](/filings/0001288469-26-000011.md) | [2.2](/filings/0001288469-26-000029.md) | [2.3](/filings/0001288469-26-000051.md) | [2.7](/filings/0001288469-26-000061.md) |
| Income tax | $m | [(4.1) d](/filings/0001288469-26-000011.md) | [(1.8)](/filings/0001288469-25-000029.md) | [(2.1)](/filings/0001288469-25-000079.md) | [(6.7)](/filings/0001288469-25-000097.md) | [17.0 d](/filings/0001288469-26-000011.md) | [0.7](/filings/0001288469-26-000029.md) | [(4.1)](/filings/0001288469-26-000051.md) | [2.1](/filings/0001288469-26-000061.md) | [(2.9) d](/filings/0001288469-26-000011.md) | [26.5](/filings/0001288469-26-000029.md) | [(8.3)](/filings/0001288469-26-000051.md) | [(0.7)](/filings/0001288469-26-000061.md) |
| Net income | $m | [(38.5) d](/filings/0001288469-26-000011.md) | [(72.3)](/filings/0001288469-25-000097.md) | [(39.3)](/filings/0001288469-25-000097.md) | [(75.8)](/filings/0001288469-25-000097.md) | [(57.8) d](/filings/0001288469-26-000011.md) | [(49.7)](/filings/0001288469-26-000061.md) | [(26.6)](/filings/0001288469-26-000061.md) | [(45.5)](/filings/0001288469-26-000061.md) | [(14.9) d](/filings/0001288469-26-000011.md) | [(45.1)](/filings/0001288469-26-000061.md) | [1.8](/filings/0001288469-26-000061.md) | [28.9](/filings/0001288469-26-000061.md) |
| Diluted EPS | $ per share | not reported | [(0.88)](/filings/0001288469-25-000029.md) | [(0.47)](/filings/0001288469-25-000079.md) | [(0.90)](/filings/0001288469-25-000097.md) | not reported | [(0.58)](/filings/0001288469-26-000029.md) | [(0.31)](/filings/0001288469-26-000051.md) | [(0.52)](/filings/0001288469-26-000061.md) | not reported | [(0.52)](/filings/0001288469-26-000029.md) | [0.02](/filings/0001288469-26-000051.md) | [0.30](/filings/0001288469-26-000061.md) |
| Basic EPS | $ per share | not reported | [(0.88)](/filings/0001288469-25-000029.md) | [(0.47)](/filings/0001288469-25-000079.md) | [(0.90)](/filings/0001288469-25-000097.md) | not reported | [(0.58)](/filings/0001288469-26-000029.md) | [(0.31)](/filings/0001288469-26-000051.md) | [(0.52)](/filings/0001288469-26-000061.md) | not reported | [(0.52)](/filings/0001288469-26-000029.md) | [0.02](/filings/0001288469-26-000051.md) | [0.32](/filings/0001288469-26-000061.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [187](/filings/0001288469-25-000008.md) | [192](/filings/0001288469-24-000064.md) | [185](/filings/0001288469-24-000112.md) | [148](/filings/0001288469-24-000128.md) | [119](/filings/0001288469-26-000011.md) | [103](/filings/0001288469-25-000029.md) | [109](/filings/0001288469-25-000079.md) | [112](/filings/0001288469-25-000097.md) | [72.8](/filings/0001288469-26-000061.md) | [61.1](/filings/0001288469-26-000029.md) | [64.8](/filings/0001288469-26-000051.md) | [81.1](/filings/0001288469-26-000061.md) |
| Current assets | $m | [488](/filings/0001288469-25-000008.md) | [445](/filings/0001288469-24-000064.md) | [398](/filings/0001288469-24-000112.md) | [328](/filings/0001288469-24-000128.md) | [323](/filings/0001288469-26-000011.md) | [320](/filings/0001288469-25-000029.md) | [330](/filings/0001288469-25-000079.md) | [284](/filings/0001288469-25-000097.md) | [249](/filings/0001288469-26-000061.md) | [249](/filings/0001288469-26-000029.md) | [299](/filings/0001288469-26-000051.md) | [391](/filings/0001288469-26-000061.md) |
| Total assets | $m | [1,080](/filings/0001288469-25-000008.md) | [1,031](/filings/0001288469-24-000064.md) | [973](/filings/0001288469-24-000112.md) | [895](/filings/0001288469-24-000128.md) | [865](/filings/0001288469-26-000011.md) | [855](/filings/0001288469-25-000029.md) | [864](/filings/0001288469-25-000079.md) | [808](/filings/0001288469-25-000097.md) | [796](/filings/0001288469-26-000061.md) | [771](/filings/0001288469-26-000029.md) | [823](/filings/0001288469-26-000051.md) | [916](/filings/0001288469-26-000061.md) |
| Current liabilities | $m | [222](/filings/0001288469-25-000008.md) | [224](/filings/0001288469-24-000064.md) | [190](/filings/0001288469-24-000112.md) | [169](/filings/0001288469-24-000128.md) | [182](/filings/0001288469-26-000011.md) | [197](/filings/0001288469-25-000029.md) | [213](/filings/0001288469-25-000079.md) | [184](/filings/0001288469-25-000097.md) | [186](/filings/0001288469-26-000061.md) | [147](/filings/0001288469-26-000029.md) | [168](/filings/0001288469-26-000051.md) | [176](/filings/0001288469-26-000061.md) |
| Total liabilities | $m | [394](/filings/0001288469-25-000008.md) | [393](/filings/0001288469-24-000064.md) | [356](/filings/0001288469-24-000112.md) | [338](/filings/0001288469-24-000128.md) | [348](/filings/0001288469-26-000011.md) | [362](/filings/0001288469-25-000029.md) | [375](/filings/0001288469-25-000079.md) | [343](/filings/0001288469-25-000097.md) | [345](/filings/0001288469-26-000061.md) | [317](/filings/0001288469-26-000029.md) | [338](/filings/0001288469-26-000051.md) | [383](/filings/0001288469-26-000061.md) |
| Long-term debt | $m | [122](/filings/0001288469-25-000008.md) | [123](/filings/0001288469-24-000064.md) | [123](/filings/0001288469-24-000112.md) | [123](/filings/0001288469-24-000128.md) | [123](/filings/0001288469-26-000011.md) | [123](/filings/0001288469-25-000029.md) | [123](/filings/0001288469-25-000079.md) | [123](/filings/0001288469-25-000097.md) | [124](/filings/0001288469-26-000061.md) | [124](/filings/0001288469-26-000029.md) | [124](/filings/0001288469-26-000051.md) | [164](/filings/0001288469-26-000061.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001288469-26-000061.md) | not reported | [0.0](/filings/0001288469-26-000051.md) | [0.0](/filings/0001288469-26-000061.md) |
| Shareholders' equity | $m | [686](/filings/0001288469-26-000011.md) | [638](/filings/0001288469-25-000097.md) | [617](/filings/0001288469-25-000097.md) | [557](/filings/0001288469-25-000097.md) | [516](/filings/0001288469-26-000061.md) | [493](/filings/0001288469-26-000061.md) | [488](/filings/0001288469-26-000061.md) | [465](/filings/0001288469-26-000061.md) | [452](/filings/0001288469-26-000061.md) | [454](/filings/0001288469-26-000061.md) | [485](/filings/0001288469-26-000061.md) | [533](/filings/0001288469-26-000061.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(16.6) d](/filings/0001288469-26-000011.md) | [16.0](/filings/0001288469-25-000029.md) | [(2.7) d](/filings/0001288469-25-000079.md) | [(30.7) d](/filings/0001288469-25-000097.md) | [(27.8) d](/filings/0001288469-26-000011.md) | [(11.4)](/filings/0001288469-26-000029.md) | [10.5 d](/filings/0001288469-26-000051.md) | [10.1 d](/filings/0001288469-26-000061.md) | [10.4 d](/filings/0001288469-26-000011.md) | [(8.9)](/filings/0001288469-26-000029.md) | [4.8 d](/filings/0001288469-26-000051.md) | [(13.6) d](/filings/0001288469-26-000061.md) |
| Capital expenditure | $m | [1.3 d](/filings/0001288469-26-000011.md) | [8.3](/filings/0001288469-25-000029.md) | [3.0 d](/filings/0001288469-25-000079.md) | [4.1 d](/filings/0001288469-25-000097.md) | [2.2 d](/filings/0001288469-26-000011.md) | [2.0](/filings/0001288469-26-000029.md) | [1.2 d](/filings/0001288469-26-000051.md) | [5.7 d](/filings/0001288469-26-000061.md) | [3.7 d](/filings/0001288469-26-000011.md) | [1.4](/filings/0001288469-26-000029.md) | [2.3 d](/filings/0001288469-26-000051.md) | [5.9 d](/filings/0001288469-26-000061.md) |
| Share repurchases | $m | [0.0 d](/filings/0001288469-26-000011.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [81.3](/filings/0001288469-24-000064.md) | [80.4](/filings/0001288469-24-000112.md) | [81.2](/filings/0001288469-24-000128.md) | [82.3](/filings/0001288469-25-000029.md) | [83.5](/filings/0001288469-25-000079.md) | [84.1](/filings/0001288469-25-000097.md) | [85.3](/filings/0001288469-26-000029.md) | [86.6](/filings/0001288469-26-000051.md) | [87.2](/filings/0001288469-26-000061.md) | [87.6](/filings/0001288469-26-000029.md) | [97.3](/filings/0001288469-26-000051.md) | [97.7](/filings/0001288469-26-000061.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 91,000,008 at 2026-10-15, from the cover of the [10-Q filed 2026-10-22](/filings/0001288469-26-000061.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.